Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Hematology
 More »

  • American Society of Hematology
    New Orleans LA UNITED STATES www.hematology.org/Meetings/Annual-Meeting
    12-7-2013
  • Array Lays Off 50 after Amgen Diabetes Collaboration Ends
    a collaboration aimed at developing new drugs against type 2 diabetes and refocus on hematology and oncology drugs. "After the 20% reduction, Array will have approximately 200 ...
    8-8-2013
  • Hematologic Diagnostics Go with the Flow
    ... Council for Standardization in Hematology is currently establishing guidelines ... International Society for Laboratory Hematology. "The main advantage of combining the ...
    8-1-2013
  • Celgene Raises Acetylon Stake with Option to Buy for Potentially...
    Alles, Celgene's evp, global head of hematology and oncology, and nonvoting observer to ... with a variety of diseases including hematology, oncology, diseases of the immune ...
    7-29-2013
  • Genentech Trumpets Phase III Results for CLL Candidate
    CLL 11 study, saying those results have been submitted for presentation at the 55th Annual Meeting of the American Society of Hematology, to be held December 7-10 in New Orleans. ...
    7-24-2013
  • M&A Doubleheader: Two Ailing Companies Bought Out
    First, through a wholly owned subsidiary, hematology and oncology-focused Spectrum ... for Marqibo® (an FDA-approved hematology product for the treatment of leukemia), ...
    7-17-2013
  • FDA Gives Nod to Boehringer NSCLC Drug, Qiagen CDx
    development of targeted treatments," Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research, said in ...
    7-12-2013
  • Roche Buys CMI, Creates Hematology Dx Hub In $220M+ Deal
    presence in the laboratory hematology testing business. CMI, Roche said, will evolve into Roche Diagnostics' center of excellence for hematology products, which now include a ...
    7-3-2013
  • Celgene, MorphoSys Ink Up to $818M Deal to Move Multiple Myeloma...
    Added Cellgene's Mark Alles, evp and global head, hematology and oncology: "This collaboration with MorphoSys enables us to rapidly advance a promising therapeutic antibody in a ...
    6-27-2013
  • 10 Industry-Venture Fund Alliances
    ... Role of partners: Jointly evaluate, fund, then work with startup companies in Bayer's areas of interest, which include cardiology, hematology, oncology, ophthalmology, and women's ...
    6-20-2013
  • Techne Buys Bionostics for $104M
    the maker of biotechnology products and hematology controls to expand its offerings to ... Bionostics will be folded by Techne into its hematology division, with the combined ...
    6-18-2013
  • Cancer's Bitter Medicine
    Writing in the American Society of Hematology journal Blood, the experts said they were compelled to advocate for lower cancer drug prices as "a necessity to save the lives of ...
    6-15-2013
  • Top 20 Corporate Venture Funds
    ... (CNS) and neuropsychiatry, gastrointestinal, hematology, and orphan genetic diseases. ... include oncology, inflammation, hematology/nephrology, metabolic disorders, ...
    6-14-2013
  • Maxygen Maxes Out
    a final $30 million from Bayer HealthCare in return for selling a recombinant factor VIIa product candidate (formerly MAXY-VII) and other hematology assets in 2008 for $90 million. ...
    6-4-2013
  • Cancer's Bitter Medicine
    Writing in the American Society of Hematology journal Blood, the experts said they were compelled to advocate for lower cancer drug prices as "a necessity to save the lives of ...
    5-21-2013
  • More »

    Journal Articles

  • Evaluation of Ocular and General Safety Following Repeated Dosing...
    Michael A. Patane, William Schubert, Thomas Sanford, Raymond Gee, Melissa Burgos, William P. Isom, Begona Ruiz-Perez
    Journal of Ocular Pharmacology and Therapeutics
    Other evaluations included toxicokinetics, ophthalmic examinations, intraocular pressure measurements, electroretinographs, clinical observations, body weight, hematology and serum ...
  • Laboratory Referral Rates of Genetic Tests for Thrombophilia...
    Rouba Hoteit, Hussein Halas, Sylvana Hassanieh, Rami A.R. Mahfouz
    Genetic Testing and Molecular Biomarkers
    referrals came from the department of Obstetrics and Gynecology, while in the medical speciality, most of the workup referrals originated from the Hematology/Oncology physicians. ...
  • Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium...
    Sun Hee Park, Chulmin Park, Su-Mi Choi, Dong-Gun Lee, Si-Hyun Kim, Jae-Cheol Kwon, Ji-Hyun Byun, Jung-Hyun Choi, Jin-Hong Yoo
    Microbial Drug Resistance
    Over a 6-year period (March 2000-February 2006), there were 60 vancomycin-resistant Enterococcus faecium (VREF) bloodstream infections (BSIs) in a hematology unit, accounting for ...
  • Nosocomial Spread of Pseudomonas aeruginosa Isolates Expressing...
    Cécile Aubron, Laurent Poirel, Nicolas Fortineau, Pierre Nicolas, Louis Collet, Patrice Nordmann
    Microbial Drug Resistance
    the Metallo-β-Lactamase VIM-2 in a Hematology Unit of a French Hospital Microbial ... Pseudomonas aeruginosa isolates in a hematology unit in Marseilles, France, from ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll